Endometrial granulomas with Levonorgestrel Intrauterine System (Mirena)

被引:3
|
作者
Charlton, Fletcher [1 ]
Otton, Geoffrey [2 ]
Hedges, Andrew [3 ]
Scurry, James [4 ]
机构
[1] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia
[2] John Hunter Hosp, Hunter Ctr Gynaecol Canc, New Lambton Hts, NSW, Australia
[3] John Hunter Hosp, Dept Gynaecol, New Lambton Hts, NSW, Australia
[4] John Hunter Hosp, Hunter Area Pathol Serv, Div Anat Pathol, New Lambton Hts, NSW, Australia
关键词
D O I
10.1097/PAT.0000000000000127
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
[No abstract available]
引用
收藏
页码:457 / 458
页数:2
相关论文
共 50 条
  • [11] The Mirena® levonorgestrel system
    McGavigan, CJ
    Cameron, IT
    [J]. DRUGS OF TODAY, 2003, 39 (12) : 973 - 984
  • [12] THE LEVONORGESTREL INTRAUTERINE SYSTEM (MIRENA) FOR MENSTRUAL CONTROL IN ADOLESCENTS WITH MENTAL DISABILITIES
    Huneeus, A.
    Schilling, A.
    Carrasco, O.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 166 - 166
  • [13] Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women
    Jozwik, Maciej
    Jozwik, Marcin
    Modzelewska, Beata
    Niewinska, Marta
    Jozwik, Michal
    [J]. GINEKOLOGIA POLSKA, 2015, 86 (04) : 305 - 310
  • [14] Endometrial adenocarcinoma following insertion of the levonorgestrel-releasing intrauterine system (mirena) in a 36-year-old woman
    Abu, J
    Brown, L
    Ireland, D
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) : 1445 - 1447
  • [15] Levonorgestrel plasma levels in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system (Mirena)
    Gschliesser, A.
    Seeber, B.
    Moser, C.
    Seger, C.
    Mattle, V.
    Concin, H.
    Wildt, L.
    [J]. HUMAN REPRODUCTION, 2011, 26 : I246 - I247
  • [16] PLASMA LEVONORGESTREL LEVELS IN WOMEN USING LNG20, A NEW LEVONORGESTREL INTRAUTERINE SYSTEM, AND MIRENA
    Gordenne, V
    Wijzen, F.
    Foidart, J-M
    Marmon, T.
    Creinin, M. D.
    Frankenne, F.
    [J]. CONTRACEPTION, 2010, 82 (02) : 193 - 193
  • [17] Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis
    Roberts, T. E.
    Tsourapas, A.
    Middleton, L. J.
    Champaneria, R.
    Daniels, J. P.
    Cooper, K. G.
    Bhattacharya, S.
    Barton, P. M.
    [J]. BRITISH MEDICAL JOURNAL, 2011, 342
  • [18] Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena®) in Campinas, Brazil
    Diaz, J
    Bahamondes, L
    Monteiro, I
    Petta, C
    Hildalgo, MM
    Arce, XE
    [J]. CONTRACEPTION, 2000, 62 (02) : 59 - 61
  • [19] Mirena® -: the levonorgestrel intrauterine system -: The new contraceptive option for parous women -: Introduction
    Johansson, EDB
    [J]. MIRENA - THE LEVONORGESTREL INTRAUTERINE SYSTEM: THE NEW CONTRACEPTIVE OPTION FOR PAROUS WOMEN, 1998, : 9 - 10
  • [20] Comparison of Mirena and Liletta levonorgestrel intrauterine devices for the treatment of endometrial intraepithelial neoplasia and grade 1 endometrioid endometrial cancer
    Chaudhari, Sonal R.
    Lai, Tiffany S.
    Zakhour, Mae
    Shin, Sim Myung
    Baltayan, Armine
    Tan, Hongying
    Cohen, Joshua G.
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2023, 49